(Q33392844)

26 July 2017

1 reference

title

Biomarkers in amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

26 July 2017

0 references

0 references

Kevin Talbot

4

0 references

Martin R. Turner

object named as

Martin R Turner

series ordinal

1

0 references

Matthew C Kiernan

series ordinal

2

object named as

Matthew C Kiernan

1 reference

26 July 2017

3

P Nigel Leigh

1 reference

26 July 2017

1 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

8

1 reference

26 July 2017

1

1 reference

26 July 2017

94-109

1 reference

The epidemiology of ALS and the role of population-based registries

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

ALS and FTLD: two faces of TDP-43 proteinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Role of axonal transport in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Molecular and cellular pathways of neurodegeneration in motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Genetics of sporadic amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Focality of upper and lower motor neuron degeneration at the clinical onset of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Electrodiagnostic criteria for diagnosis of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Preclinical and subclinical events in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Motor neuron disease presenting with respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Prognosis of amyotrophic lateral sclerosis with respiratory onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

The management of motor neurone disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Design, power, and interpretation of studies in the standard murine model of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Assessment of disease progression in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Protein biomarkers for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Free amino acid levels in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Plasma amino acids percentages in amyotrophic lateral sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Decreased plasma levels of fibronectin in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Increased serum hyaluronic acid in amyotrophic lateral sclerosis: Relation to its skin content

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Elevated serum angiogenin levels in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Skin involvement in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Safety and acceptability of the research lumbar puncture.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Axonal damage markers in cerebrospinal fluid are increased in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Substance P receptors in the human spinal cord: decrease in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Identification of potential CSF biomarkers in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

MRI and clinical features in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Diffusion tensor MRI assesses corticospinal tract damage in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Spatial profiling of the corticospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Frontotemporal white matter changes in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Subcortical motor plasticity in patients with sporadic ALS: An fMRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Magnetic source imaging of cortical dysfunction in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

MRI in patients with amyotrophic lateral sclerosis: correlation with clinical features.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Reversible diffusion MRI abnormalities and transient mutism after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

The basis of anisotropic water diffusion in the nervous system - a technical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Diffusion-based tractography in neurological disorders: concepts, applications, and future developments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Voxel-based morphometry–the methods

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Double cortical stimulation in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

1 reference

7 January 2021

Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Electrophysiologic evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Motor unit number estimation in human neurological diseases and animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Statistical motor unit number estimation: from theory to practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Effect of changing data collection parameters on statistical motor unit number estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

The use of statistical MUNE in a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Bayesian statistical MUNE method.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Excitability of human axons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Distal excitability changes in motor axons in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Axonal excitability properties in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

The Neurophysiological Index in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Expression of Nogo-A in human muscle fibers is not specific for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970293-X

7 January 2021

10.1016/S1474-4422(08)70293-X

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

19081518